Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05605899 |
|---|---|
| Brief Title: | Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma (ZUMA-23) |
| First Submitted : | October 31, 2022 |
| First Submitted that Met QC Criteria : | October 31, 2022 |
| First Posted : | November 4, 2022 |
| Last Update Submitted that Met QC Criteria : | April 23, 2024 |
| Last Update Posted : | April 25, 2024 |